148 related articles for article (PubMed ID: 11258401)
1. The optimal imaging time for [99Tcm]TRODAT-1/SPET in normal subjects and patients with Parkinson's disease.
Kao PF; Tzen KY; Yen TC; Lu CS; Weng YH; Wey SP; Ting G
Nucl Med Commun; 2001 Feb; 22(2):151-4. PubMed ID: 11258401
[TBL] [Abstract][Full Text] [Related]
2. Imaging of dopamine transporters with technetium-99m TRODAT-1 and single photon emission computed tomography.
Bao SY; Wu JC; Luo WF; Fang P; Liu ZL; Tang J
J Neuroimaging; 2000 Oct; 10(4):200-3. PubMed ID: 11147397
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-TRODAT-1 imaging of multiple system atrophy.
Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC
J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.
Weng YH; Yen TC; Chen MC; Kao PF; Tzen KY; Chen RS; Wey SP; Ting G; Lu CS
J Nucl Med; 2004 Mar; 45(3):393-401. PubMed ID: 15001678
[TBL] [Abstract][Full Text] [Related]
5. Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.
Swanson RL; Newberg AB; Acton PD; Siderowf A; Wintering N; Alavi A; Mozley PD; Plossl K; Udeshi M; Hurtig H
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):302-7. PubMed ID: 15791439
[TBL] [Abstract][Full Text] [Related]
6. Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers.
Mozley PD; Schneider JS; Acton PD; Plössl K; Stern MB; Siderowf A; Leopold NA; Li PY; Alavi A; Kung HF
J Nucl Med; 2000 Apr; 41(4):584-9. PubMed ID: 10768556
[TBL] [Abstract][Full Text] [Related]
7. Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease.
Geng Y; Shi GH; Jiang Y; Xu LX; Hu XY; Shao YQ
J Zhejiang Univ Sci B; 2005 Jan; 6(1):22-7. PubMed ID: 15593387
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats.
Dresel SH; Kung MP; Plössl K; Meegalla SK; Kung HF
Eur J Nucl Med; 1998 Jan; 25(1):31-9. PubMed ID: 9396872
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.
Lynch DR; Mozley PD; Sokol S; Maas NM; Balcer LJ; Siderowf AD
Mov Disord; 2003 Jul; 18(7):804-12. PubMed ID: 12815660
[TBL] [Abstract][Full Text] [Related]
10. Single photon emission computer tomography of dopamine transporters in monkeys and humans with 99mTc-TRODAT-1.
Hu P; Chen L; Zhang HQ; Li JR; Liang H
Chin Med J (Engl); 2004 Jul; 117(7):1056-9. PubMed ID: 15265382
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease.
Hwang WJ; Yao WJ; Wey SP; Ting G
J Nucl Med; 2004 Feb; 45(2):207-13. PubMed ID: 14960637
[TBL] [Abstract][Full Text] [Related]
12. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
Weintraub D; Newberg AB; Cary MS; Siderowf AD; Moberg PJ; Kleiner-Fisman G; Duda JE; Stern MB; Mozley D; Katz IR
J Nucl Med; 2005 Feb; 46(2):227-32. PubMed ID: 15695780
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters.
Mozley PD; Stubbs JB; Plössl K; Dresel SH; Barraclough ED; Alavi A; Araujo LI; Kung HF
J Nucl Med; 1998 Dec; 39(12):2069-76. PubMed ID: 9867143
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.
Tzen KY; Lu CS; Yen TC; Wey SP; Ting G
J Nucl Med; 2001 Mar; 42(3):408-13. PubMed ID: 11337515
[TBL] [Abstract][Full Text] [Related]
15. In vivo imaging of serotonin transporters with [99mTc]TRODAT-1 in nonhuman primates.
Dresel SH; Kung MP; Huang X; Plössl K; Hou C; Shiue CY; Karp J; Kung HF
Eur J Nucl Med; 1999 Apr; 26(4):342-7. PubMed ID: 10199939
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients.
Hsiao IT; Weng YH; Lin WY; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lu CS; Lin KJ
Nucl Med Biol; 2014 Apr; 41(4):322-9. PubMed ID: 24503330
[TBL] [Abstract][Full Text] [Related]
17. Imaging early-stage corticobasal degeneration with [99mTc]TRODAT-1 SPET.
Lai SC; Weng YH; Yen TC; Tsai CC; Chang HC; Wey SP; Ting G; Lu CS
Nucl Med Commun; 2004 Apr; 25(4):339-45. PubMed ID: 15097807
[TBL] [Abstract][Full Text] [Related]
18. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.
Booij J; Speelman JD; Horstink MW; Wolters EC
Eur J Nucl Med; 2001 Mar; 28(3):266-72. PubMed ID: 11315592
[TBL] [Abstract][Full Text] [Related]
19. Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography.
Tatsch K; Schwarz J; Mozley PD; Linke R; Pogarell O; Oertel WH; Fieber RS; Hahn K; Kung HF
Eur J Nucl Med; 1997 Apr; 24(4):415-21. PubMed ID: 9096093
[TBL] [Abstract][Full Text] [Related]
20. Logistic discriminant parametric mapping: a novel method for the pixel-based differential diagnosis of Parkinson's disease.
Acton PD; Mozley PD; Kung HF
Eur J Nucl Med; 1999 Nov; 26(11):1413-23. PubMed ID: 10552082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
